ClinicalTrials.Veeva

Menu

Pre-implantation Genetic Testing for Monogenic Disease: Single Center Experience

I

Istituto Clinico Humanitas

Status

Completed

Conditions

Aneuploidy
Genetic Disease

Treatments

Genetic: Pre-implantation genetic testing

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This monocentric retrospective observational study aims to evaluate the efficacy of pre-implantation genetic testing for monogenic diseases (PGT-M). The effectiveness will be assessed in terms of live birth rate (LBR), cumulative live birth rate (CLBR) per couple, and abortion rate (AR). Considering how many cycles the participants have undergone to achieve a viable blastocyst. The secondary objective is to evaluate the incidence of aneuploidy in unaffected embryos, in order to understand the need for pre-implantation genetic testing for aneuploidy (PGT-A)in addition to PGT-M.

Enrollment

76 patients

Sex

Female

Ages

34 to 42 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients fertile or infertile that have undergone preimplantation genetic testing for monogenic diseases (PGTM).

Exclusion criteria

  • No exclusion criteria will be taken into consideration.

Trial design

Trial documents
2

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems